HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nikolaos Vardakis Selected Research

gemcitabine-oxaliplatin regimen

1/2008Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
12/2006Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nikolaos Vardakis Research Topics

Disease

12Neoplasms (Cancer)
08/2021 - 01/2005
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 12/2006
5Neutropenia
08/2011 - 08/2003
4Adenocarcinoma
11/2018 - 01/2010
4Febrile Neutropenia
08/2011 - 08/2003
3Breast Neoplasms (Breast Cancer)
01/2022 - 11/2004
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2012 - 01/2004
2Ovarian Neoplasms (Ovarian Cancer)
06/2019 - 01/2008
2Carcinoma (Carcinomatosis)
01/2018 - 03/2012
2Brain Neoplasms (Brain Tumor)
07/2012 - 01/2009
2Diarrhea
06/2011 - 08/2003
1Weight Loss (Weight Reduction)
08/2021
1Cachexia
08/2021
1Ovarian Epithelial Carcinoma
06/2019
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Venous Thromboembolism
09/2013
1Body Weight (Weight, Body)
07/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2012
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2010
1Lung Neoplasms (Lung Cancer)
01/2009
1Disease Progression
12/2006
1Thrombocytopenia (Thrombopenia)
08/2003
1Fever (Fevers)
08/2003
1Rectal Neoplasms (Rectal Cancer)
08/2003
1Hand-Foot Syndrome
08/2003
1Abdominal Pain (Pain, Abdominal)
08/2003

Drug/Important Bio-Agent (IBA)

7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2010 - 01/2005
6GemcitabineFDA Link
06/2019 - 01/2004
6Paclitaxel (Taxol)FDA LinkGeneric
07/2012 - 01/2007
5Docetaxel (Taxotere)FDA Link
11/2018 - 05/2011
4Cisplatin (Platino)FDA LinkGeneric
11/2018 - 12/2006
4Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 11/2004
4Vinorelbine (Navelbine)FDA LinkGeneric
02/2013 - 11/2004
3Bevacizumab (Avastin)FDA Link
01/2022 - 07/2011
3Leucovorin (Folinic Acid)FDA Link
11/2018 - 11/2004
3Irinotecan (Camptosar)FDA LinkGeneric
07/2011 - 01/2004
3PlatinumIBA
03/2011 - 01/2008
2Taxoids (Taxanes)IBA
01/2022 - 11/2004
2taxaneIBA
01/2018 - 12/2006
2liposomal doxorubicin (Doxil)FDA Link
07/2011 - 08/2008
2Capecitabine (Xeloda)FDA Link
01/2007 - 08/2003
1Immune Checkpoint InhibitorsIBA
08/2021
1B7-H1 AntigenIBA
08/2021
1Programmed Cell Death 1 ReceptorIBA
08/2021
1Topotecan (Hycamtin)FDA LinkGeneric
06/2019
1Panitumumab (Vectibix)FDA Link
11/2018
1130-nm albumin-bound paclitaxelIBA
01/2018
1AnticoagulantsIBA
09/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2012
1Pemetrexed (MTA)FDA Link
08/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2011
1thiamine triphosphorate (TTP)IBA
05/2011
1Carboplatin (JM8)FDA LinkGeneric
03/2011
1RNA (Ribonucleic Acid)IBA
01/2011
1Temozolomide (Temodar)FDA LinkGeneric
01/2009
1AnthracyclinesIBA
11/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2004

Therapy/Procedure

10Drug Therapy (Chemotherapy)
01/2022 - 08/2003
3Salvage Therapy
06/2019 - 07/2011
2Therapeutics
01/2022 - 08/2021
2Radiotherapy
07/2012 - 08/2003
2gemcitabine-oxaliplatin regimen
01/2008 - 12/2006
2Treatment Delay
01/2007 - 08/2003
1Immunotherapy
08/2021
1Operative Surgical Procedures
08/2021
1Combination Drug Therapy (Combination Chemotherapy)
06/2019
1Metastasectomy
11/2018